Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilt

Showing results (791-800 of 846) with videos related to

Pageof 85
Sort By:
Plos One|July 22, 2016
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern AfricaCarlo Zambonelli, Antu K Dey, Susan Hilt, et al.
The Science of the Total Environment|May 6, 2024
Causes of macrophyte mass development and management recommendationsSusanne C Schneider, Julie A Coetzee, Elena Fukasawa Galvanese, et al.
ACS Nano|August 2, 2022
Topological Stone-Wales Defects Enhance Bonding and Electronic Coupling at the Graphene/Metal InterfaceBenedikt P Klein, Alexander Ihle, Stefan R Kachel, et al.
BMC Genomics|April 5, 2022
Genomic epidemiology of the Los Angeles COVID-19 outbreak and the early history of the B.1.43 strain in the USALonghua Guo, James Boocock, Evann E Hilt, et al.
British Journal of Clinical Pharmacology|July 27, 2005
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693J P van der Post, S J de Visser, M L de Kam, et al.
International Urogynecology Journal|October 2, 2015
Incontinence medication response relates to the female urinary microbiotaKrystal J Thomas-White, Evann E Hilt, Cynthia Fok, et al.
Iscience|April 1, 2024
Oleic acid triggers metabolic rewiring of T cells poising them for T helper 9 differentiationNathalie A Reilly, Friederike Sonnet, Koen F Dekkers, et al.
Journal of Virology|May 18, 2001
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable regionS W Barnett, S Lu, I Srivastava, et al.
Nanoscale|March 1, 2024
Probing the role of surface termination in the adsorption of azupyrene on copperBenedikt P Klein, Matthew A Stoodley, Dylan B Morgan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 14, 2023
A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy ControlsJonas M den Heijer, Valerie C Cullen, Diana R Pereira, et al.
Pageof 85

Showing results (791-800 of 846) with videos related to

Sort By:
Pageof 85
Plos One|July 22, 2016
Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern AfricaCarlo Zambonelli, Antu K Dey, Susan Hilt, et al.
The Science of the Total Environment|May 6, 2024
Causes of macrophyte mass development and management recommendationsSusanne C Schneider, Julie A Coetzee, Elena Fukasawa Galvanese, et al.
ACS Nano|August 2, 2022
Topological Stone-Wales Defects Enhance Bonding and Electronic Coupling at the Graphene/Metal InterfaceBenedikt P Klein, Alexander Ihle, Stefan R Kachel, et al.
BMC Genomics|April 5, 2022
Genomic epidemiology of the Los Angeles COVID-19 outbreak and the early history of the B.1.43 strain in the USALonghua Guo, James Boocock, Evann E Hilt, et al.
British Journal of Clinical Pharmacology|July 27, 2005
The central nervous system effects, pharmacokinetics and safety of the NAALADase-inhibitor GPI 5693J P van der Post, S J de Visser, M L de Kam, et al.
International Urogynecology Journal|October 2, 2015
Incontinence medication response relates to the female urinary microbiotaKrystal J Thomas-White, Evann E Hilt, Cynthia Fok, et al.
Iscience|April 1, 2024
Oleic acid triggers metabolic rewiring of T cells poising them for T helper 9 differentiationNathalie A Reilly, Friederike Sonnet, Koen F Dekkers, et al.
Journal of Virology|May 18, 2001
The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable regionS W Barnett, S Lu, I Srivastava, et al.
Nanoscale|March 1, 2024
Probing the role of surface termination in the adsorption of azupyrene on copperBenedikt P Klein, Matthew A Stoodley, Dylan B Morgan, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 14, 2023
A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy ControlsJonas M den Heijer, Valerie C Cullen, Diana R Pereira, et al.
Pageof 85